Author

Mendel Goldfinger

Albert Einstein College of MedicineORCID 0000-0002-4347-173XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Abdullah KhasawnehiD· 1 shared Aditi ShastriiD· 1 shared Amit K. VermaiD· 1 shared Anna SkwarskaiD· 1 shared B. W. Brown· 1 shared Bianca Rivera-PeñaiD· 1 shared Claudia MorgantiiD· 1 shared Divij VermaiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Abdullah KhasawnehORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A STAT3 Degrader Demonstrates Pre-clinical Efficacy in Venetoclax resistant Acute Myeloid Leukemia

Samarpana Chakraborty, Claudia Morganti, Kimberly S. Zaldana, Bianca Rivera-Peña, H. Zhang, Divij Verma, Nadege Gitego, Feiyang Ma, Srinivas Aluri, Kith Pradhan, Shanisha Gordon-Mitchell, Ioannis Mantzaris, Mendel Goldfinger, Eric Jay Feldman, Kira Gritsman, , Aditi Shastri

This paper shows that targeting STAT3 with a degrader can overcome Venetoclax resistance in AML by reducing MCL1 and improving mitochondrial function.

Leukemia · Feb 17, 2026Peer-reviewedCancer Biology